BACK (IMAC Holdings) 3-1 Month Momentum %: -33.22% (As of Jul. 13, 2026)


What is IMAC Holdings 3-1 Month Momentum %?

IMAC Holdings BACK 3-1 Month Momentum % is -33.22% as of Jul. 13, 2026. The stock has 7 warning signs investors should review. Among 681 Healthcare Providers & Services companies, IMAC Holdings ranks worse than 93.54% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-13), IMAC Holdings's 3-1 Month Momentum % is -33.22%.

The industry rank for IMAC Holdings's 3-1 Month Momentum % or its related term are showing as below:

BACK's 3-1 Month Momentum % is ranked worse than
93.54% of 681 companies
in the Healthcare Providers & Services industry
Industry Median: -3.52 vs BACK: -33.22

IMAC Holdings  (OTCPK:BACK) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

IMAC Holdings 3-1 Month Momentum % Related Terms

BACK vs FCHS, NHLG, PAIYY: 3-1 Month Momentum % Comparison

For the Medical Care Facilities subindustry, IMAC Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMAC Holdings 3-1 Month Momentum % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where IMAC Holdings's 3-1 Month Momentum % falls into.


IMAC Holdings  (OTCPK:BACK) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -33.22% mean?
IMAC Holdings (BACK) has a 3-1 Month Momentum % of -33.22% as of Jul. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on IMAC Holdings and its competitors. According to the industry distribution chart, IMAC Holdings ranks #637 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 93.5%.
Is IMAC Holdings' 3-1 Month Momentum % too high?
IMAC Holdings' current 3-1 Month Momentum % is -33.22%. Based on the distribution chart, IMAC Holdings ranks #637 out of 681 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does IMAC Holdings' 3-1 Month Momentum % compare to FCHS and NHLG?
According to the Healthcare Providers & Services industry distribution chart, IMAC Holdings ranks #637 out of 681 companies for 3-1 Month Momentum %. This places IMAC Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on IMAC Holdings and its competitors. IMAC Holdings's current 3-1 Month Momentum % is -33.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current 3-1 Month Momentum % of -33.22%. The current 3-1 Month Momentum % is -33.22%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For IMAC Holdings (BACK), the current 3-1 Month Momentum % is -33.22% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMAC Holdings Business Description

Address 3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.